Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study

Intramuscular neridronate for the treatment of complex regional pain syndrome type 1: a randomized, double-blind, placebo-controlled study

Background: Complex regional pain syndrome type-1 (CRPS-1) is a severely disabling painful disease challenging to treat. This multicenter, randomized, double-blind placebo-controlled trial examined the efficacy of intramuscular (i.m.) neridronate in CRPS-1 patients. Methods: A total of 78 patients d...

Full description

Bibliographic Details
Main Authors: Massimo Varenna, Vania Braga, Davide Gatti, Giovanni Iolascon, Bruno Frediani, Francesca Zucchi, Chiara Crotti, Fabrizio Nannipieri, Maurizio Rossini
Format: Article
Language:English
Published: SAGE Publishing 2021-06-01
Series:Therapeutic Advances in Musculoskeletal Disease
Online Access:https://doi.org/10.1177/1759720X211014020

Internet

https://doi.org/10.1177/1759720X211014020

Similar Items